Date:10/15/2009

$-- $3,000 Accounts payable 4,439 4,221 Accrued expenses 2,218 2,575 Deferred income 361 1,228 Other long term debt 4,457 4,185 Deferred income taxes 1,200 2,152 6% Series I Convertible preferred stock subject to mandatory redemption -- 3,270 8% Series J Convertible preferred stock subject to mandatory redemption 13,218 11,594 Total Liabilities 25,893 32,225 Stockholders' Equity (DEFICIT) (11,070) 7,401 Total Liabilities, and Stockholders' Equity (DEFICIT) $14,823 $39,626 NUTRITION 21, INC. Consolidated Statements of Operations (In thousands, except share and per share data) (unaudited) Quarter ended Year ended June 30, June 30, 2009 2008 2009 2008 Net sales $5,343 $10,906 $39,257 $46,363 Other revenues 105 139 348 708 Total Revenues 5,448 11,045 39,605 47,071 Costs and Expenses Cost of Revenues 3,233 3,415 16,397 17,609 Advertising & Promotion General and Administrative 3,8961,141 5,3391,429 17,7073,883 33,4786,197 Research and Development 98 110 364 954 Depreciation and Amortization 196 551 1,106
'/>"/>

SOURCE Nutrition 21, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6
Related biology technology :

1. Salugen Announces the U.S. Launch of GenoTrim - a DNA Customized Nutritional Solution for Weight Management
2. BitWine (TM) Nutrition Advisors Network Expands Roster of Licensed Dietitians and Nutritionists
3. Salugen to Present at Nutrition Capital Networks First In-Person Investor Meeting
4. CNCA Exceeds Standards in Nutritional Supplement Quality, Protects Public
5. Pilot Therapeutics Announces New Executive Team with Extensive Experience Creating New Health and Nutrition Businesses
6. Salugen Expands U.S. Distribution and Announces a Partnership with DNA Dimensions to Bring DNA Customized Nutritional Solutions to Metro Detroit Area
7. Salugens Award-Winning Research on Using DNA Information to Customize Nutritional Supplementation for Weight Loss Presented at the Second Annual Bruce Ames International Symposium on Nutritional Genomics at the University of California, Davis
8. Natural Nutrition Launches International Marketing Campaign for New All Natural Analgesic: BLUE LIGHTNING(TM) Fast Pain Relief
9. Millennium Biotechnologies, Inc. Launches SURGEX(TM) the First Scientifically Validated Sports Nutritional Product Created from the Medical Markets
10. Max Nutrition, Inc. Completes Share Exchange with American Spring Pharmaceutical, Inc.
11. Nutrition 21 to Report Second Quarter Fiscal 2008 Financial Results Monday, February 11, 2008